Protara Therapeutics, Inc. — Director's Dealing 2016

Sep 1, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROTEON THERAPEUTICS INC (PRTO)
CIK: 0001359931
Period of Report: 2016-08-31

Reporting Person: Toner E. Scott (Senior VP of Marketing)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-31	Common Stock	G	50	—	Disposed	135	Direct

Footnotes

F1: This transaction involved a gift of securities by the reporting person to his grandson.